Product Image

Think Support

Zoi Research
4.6
★ ★ ★ ★ ★
(4130 ratings)
Ginkgo
Bacopa 200 mg
Product Image
Score55
A plausible bacopa-ginkgo core is weakened by modest bacopa, missing marker percentages, and three hidden blends.
How scoring works
Quantity:60 Capsule(s) • (30 servings)
Goals:

Score 55

A plausible bacopa-ginkgo core is weakened by modest bacopa, missing marker percentages, and three hidden blends.
How scoring works
$17.67($0.58 per serving)
iHerb
$ 17.67
Report prices

Analysis

Bacopa and ginkgo are sensible core ingredients for long-term memory and cerebral-circulation support. The formula is more relevant to cognition than to direct vision protection.

Bacopa falls below a common researched range and does not state its bacoside level. Ginkgo has a useful listed weight but no active-marker percentages or purity limit.

Three proprietary blends conceal ingredients or amounts that could change both benefit and safety. That opacity makes the product less convincing than a fully disclosed two-ingredient formula.

Who is it for
  • Adults seeking basic long-term cognitive support
  • People comfortable with proprietary blends
Best for
  • Memory and circulation support
  • Non-stimulant cognitive routines

Pros

  • Includes both bacopa and ginkgo
  • Named actives have individually listed weights
  • Targets complementary cognitive pathways

Cons

  • Bacopa amount is below common researched use
  • Active-marker standardization is missing
  • Three proprietary blends obscure the formula
  • Limited direct vision support

Warnings

  • Ginkgo may increase bleeding tendency with warfarin, direct oral anticoagulants, aspirin, or other antiplatelet medicines
  • Bacopa can cause digestive upset or drowsiness
  • Hidden proprietary-blend ingredients prevent complete interaction screening

Nutrient quality

66 High impact

Bacopa and ginkgo provide a relevant cognitive foundation but lack complete standardization. Hidden supporting blends and a modest bacopa amount are the main quality weaknesses.

.

Ingredient transparency

39 Lower impact

Several named actives have clear amounts, but proprietary components conceal important formula detail. Missing daily directions, excipients, and complete form information further limit label clarity.

.

Customer satisfaction

71 High impact

A strong supplied average is supported by a very large review base. Specific review comments were not provided, so repeated complaints and purpose-specific experiences cannot be assessed.

.

Value for money

49 Lower impact

Useful bacopa and ginkgo amounts provide some practical value. Hidden blends and incomplete active-marker disclosure prevent a confident category comparison.

.
Report analysis

Goals

Mental Focus
Impact
Moderate effect
B+ Goal FitD+ Strength of SupportC CoverageC- Formula Quality

Bacopa and ginkgo provide complementary long-term memory and circulation support. Their stated amounts are plausible, but the product is unlikely to deliver an immediate alertness effect.

Three proprietary blends hide much of the composition and prevent a clear assessment of active dosing. Ginkgo may increase bleeding tendency with anticoagulant or antiplatelet medicines, and bacopa may cause digestive upset.

Study evidence
Bacopa Supportive 13 studies
Ginkgo Supportive 28 studies
Cognitive Support
Impact
Moderate effect
A- Goal FitD Strength of SupportC CoverageD+ Formula Quality
Bacopa · 200 mg

Bacopa and ginkgo directly address memory and cerebral circulation, creating strong conceptual alignment with cognitive support. Their stated amounts are useful, but Bacopa is below the common researched range and neither extract has active-marker standardization.

Three proprietary blends hide much of the formula and make meaningful dose balance impossible to verify. Ginkgo may increase bleeding risk with warfarin, direct oral anticoagulants, aspirin, or other antiplatelet medicines.

Study evidence
Bacopa Supportive 30 studies
Ginkgo Supportive 87 studies
Productivity Boost
Impact
Moderate effect
B- Goal FitD+ Strength of SupportC CoverageC Formula Quality

Ginkgo and bacopa may support circulation, memory, and learning during long-term use. Their relevance to productivity is plausible, but neither ingredient reliably creates an immediate or broadly proven focus effect.

The ginkgo amount is useful, while bacopa is below a common researched range and neither extract states active-marker standardization. Ginkgo may increase bleeding risk with warfarin, direct oral anticoagulants, aspirin, or other antiplatelet medicines.

Study evidence
Bacopa Supportive 12 studies
Ginkgo Supportive 20 studies
Ginkgo Supportive 12 studies
Brain Health
Impact
Moderate effect
B+ Goal FitD Strength of SupportC CoverageC- Formula Quality
Bacopa · 200 mg

Bacopa and ginkgo provide relevant memory and cerebral-circulation pathways in a clearly cognitive formula. Both named extracts lack active-marker standardization, and several proprietary blends obscure the supporting ingredients.

The combination offers useful breadth but limited depth because Bacopa is below a common researched amount and hidden blends cannot be assessed. Ginkgo may increase bleeding risk with anticoagulants, aspirin, or other antiplatelet medicines.

Study evidence
Bacopa Supportive 17 studies
Ginkgo Supportive 90 studies
Vision Support
Impact
Moderate effect
C- Goal FitC Strength of SupportD- CoverageD- Formula Quality

Ginkgo may support ocular circulation, but the cognitive blend is not designed for long-term retinal or macular protection. Bacopa and the hidden botanical blends add little direct vision evidence.

The ginkgo amount is potentially useful, yet standardization is not shown and several proprietary blends conceal their contents. Ginkgo can increase bleeding risk with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 11 studies

Ingredients

IngredientAmount per serving
Proprietary Blend
300 mg
Proprietary Think Support Blend
200 mg
Bacopa monnieri herb extract
200 mg
Ginkgo leaf extract
120 mg
Proprietary Absorption Blend
23 mg
Adults 18–50 Dairy Free
Report overview
Ginkgo · 120 mg OverallScore35
F Active Ingredient Quality & BioavailabilityB+ Dose, Safety & Label TransparencyF Value

The formula provides a clearly stated 120 mg of ginkgo extract alongside bacopa, but it gives no active-marker standardization or ginkgolic acid limit. Proprietary blends also obscure some of the supporting ingredients, weakening transparency and making the serving's value difficult to verify. Ginkgo may increase bleeding risk with warfarin, direct oral anticoagulants, aspirin, or other antiplatelet medicines.

Bacopa · 200 mg OverallScore24
F Active Ingredient Quality & BioavailabilityF Dose, Safety & Label TransparencyD- Value

The 200 mg bacopa extract falls below the usual researched range and lacks bacoside standardization. Its exact bacopa amount is listed, but the surrounding proprietary blends and unspecified plant part limit clarity. Value is only moderate because neither extract quality nor active yield can be verified.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
    Tan MS; Yu JT; Tan CC; Wang HF; Meng XF; Wang C; Jiang T; Zhu XC; Tan L · Journal of Alzheimer's disease : JAD · 2015
    Meta-analysis2,561 participants9 studies pooledBrain Health forGinkgo
  2. Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
    von Gunten A; Schlaefke S; Überla K · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2017
    Meta-analysis1,628 participants4 studies pooledCognitive Support Brain Health forGinkgo
  3. Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract.
    Kongkeaw C; Dilokthornsakul P; Thanarangsarit P; Limpeanchob N; Norman Scholfield C · Journal of ethnopharmacology · 2014
    Meta-analysis518 participants9 studies pooledBrain Health Mental Focus Productivity Boost forBacopa
  4. The effect of plant active substances on cognitive function in healthy older adults: a systematic review and network meta-analysis of randomized controlled trials.
    Feng X; Fan S; Wei F · Frontiers in pharmacology · 2026
    Meta-analysis1,861 participants25 studies pooledCognitive Support Brain Health forBacopa
  5. Effect of Ginkgo biloba extracts in the prevention of posterior capsule opacification after cataract surgery: A randomized clinical trial.
    Amiri AA; Jafari R; Amiri AA; Rad HA; Daneshvar F; Charati JY; Amiri AA · Oman journal of ophthalmology · 2025
    Randomized trial144 participantsVision Support forGinkgo
  6. Ginkgo biloba for cognitive impairment and dementia.
    Wieland LS; Ludeman E; Chi Y; Feinberg TM; Chen IH; Chen KH; Zhu Y; Wolverson E; Amri H · The Cochrane database of systematic reviews · 2026
    Meta-analysis10,613 participants82 studies pooledBrain Health Cognitive Support forGinkgo
  7. Comparative effects of Bacopa monnieri and Ginkgo biloba on cognitive functions: A systematic review and network meta-analysis.
    Tiemtad P; Ingkaninan K; Temkitthawon P; Thimkorn P; Rattanachaisit N; Teaktong T; Dhippayom T · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2026
    Meta-analysis2,107 participants29 studies pooledCognitive Support Brain Health Mental Focus forBacopa
  8. Dietary Supplement Ingredients for Optimizing Cognitive Performance Among Healthy Adults: A Systematic Review.
    Crawford C; Boyd C; Deuster PA · Journal of alternative and complementary medicine (New York, N.Y.) · 2021
    Systematic review69 studies pooledBrain Health forBacopa
  9. Ginkgo biloba--an appraisal.
    Dubey AK; Shankar PR; Upadhyaya D; Deshpande VY · Kathmandu University medical journal (KUMJ) · 2007
    Narrative reviewVision Support forGinkgo
  10. Comparative efficacy of Medhya Rasayana,Bacopa monnieri, and Centella asiatica in enhancing memory and IQ of 8-10 year-old healthy boys: A prakriti-based double-blind, randomized controlled trial.
    Verma J; Rathi R; Anamika; Rathi B; Pandey VB · Journal of Ayurveda and integrative medicine · 2025
    Randomized trial180 participantsBrain Health Cognitive Support forBacopa
  11. Plant-derived nootropics and human cognition: A systematic review.
    Lorca C; Mulet M; Arévalo-Caro C; Sanchez MÁ; Perez A; Perrino M; Bach-Faig A; Aguilar-Martínez A; Vilella E; Gallart-Palau X; Serra A · Critical reviews in food science and nutrition · 2023
    Systematic review256 studies pooledBrain Health forBacopa
  12. Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
    Riepe M; Hoerr R; Schlaefke S · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2025
    Meta-analysis782 participants4 studies pooledBrain Health Productivity Boost forGinkgo
  13. Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
    Cui M; You T; Zhao Y; Liu R; Guan Y; Liu J; Liu X; Wang X; Dong Q · Frontiers in pharmacology · 2023
    Randomized trial201 participantsBrain Health Productivity Boost forGinkgo
  14. Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
    Herrschaft H; Nacu A; Likhachev S; Sholomov I; Hoerr R; Schlaefke S · Journal of psychiatric research · 2012
    Randomized trial410 participantsBrain Health forGinkgo
  15. The cognitive-enhancing effects of Bacopa monnieri: a systematic review of randomized, controlled human clinical trials.
    Pase MP; Kean J; Sarris J; Neale C; Scholey AB; Stough C · Journal of alternative and complementary medicine (New York, N.Y.) · 2012
    Systematic review6 studies pooledCognitive Support Productivity Boost forBacopa
  16. A systematic review of the Ayurvedic medicinal herb Bacopa monnieri in child and adolescent populations.
    Kean JD; Downey LA; Stough C · Complementary therapies in medicine · 2017
    Systematic review5 studies pooledCognitive Support forBacopa
  17. Efficacy of Standardized Extract of Bacopa monnieri (Bacognize®) on Cognitive Functions of Medical Students: A Six-Week, Randomized Placebo-Controlled Trial.
    Kumar N; Abichandani LG; Thawani V; Gharpure KJ; Naidu MU; Venkat Ramana G · Evidence-based complementary and alternative medicine : eCAM · 2024
    Randomized trial60 participantsCognitive Support forBacopa
  18. Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
    Tian X; Xu Q; Xia X; Zhang Y; Meng X; Wang A · Journal of neurology · 2024
    Randomized trial3,163 participantsCognitive Support forGinkgo
  19. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
    Le Bars PL; Katz MM; Berman N; Itil TM; Freedman AM; Schatzberg AF · JAMA · 1997
    Randomized trial309 participantsCognitive Support Productivity Boost forGinkgo
  20. Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
    Bachinskaya N; Hoerr R; Ihl R · Neuropsychiatric disease and treatment · 2011
    Randomized trial410 participantsCognitive Support forGinkgo
  21. Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
    Ihl R; Bachinskaya N; Korczyn AD; Vakhapova V; Tribanek M; Hoerr R; Napryeyenko O; GOTADAY Study Group · International journal of geriatric psychiatry · 2013
    Randomized trial410 participantsCognitive Support forGinkgo
  22. Evaluating the effects of Bacopa monnieri on cognitive performance and sleep quality of patients with mild cognitive impairment: A triple-blinded, randomized, placebo-controlled trial.
    Delfan M; Kordestani-Moghaddam P; Gholami M; Kazemi K; Mohammadi R · Explore (New York, N.Y.) · 2024
    Randomized trial62 participantsMental Focus forBacopa
  23. Cognitive effects of two nutraceuticals Ginseng and Bacopa benchmarked against modafinil: a review and comparison of effect sizes.
    Neale C; Camfield D; Reay J; Stough C; Scholey A · British journal of clinical pharmacology · 2013
    Systematic reviewMental Focus forBacopa
  24. Efficiency of Different Supplements in Alleviating Symptoms of ADHD with or Without the Use of Stimulants: A Systematic Review.
    Al Shahab S; Al Balushi R; Qambar A; Abdulla R; Qader M; Abdulla S; Jahrami H · Nutrients · 2025
    Systematic reviewMental Focus forBacopa
  25. Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review.
    Hort J; Duning T; Hoerr R · Neuropsychiatric disease and treatment · 2023
    Systematic review946 participants9 studies pooledMental Focus forGinkgo
  26. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2012
    Randomized trial216 participantsMental Focus forGinkgo
  27. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Pharmacopsychiatry · 1996
    Randomized trial216 participantsMental Focus forGinkgo
  28. Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.
    Li S; Zhang X; Fang Q; Zhou J; Zhang M; Wang H; Chen Y; Xu B; Wu Y; Qian L; Xu Y · Stroke and vascular neurology · 2021
    Randomized trial348 participantsMental Focus forGinkgo
  29. Ginkgo biloba in the Aging Process: A Narrative Review.
    Barbalho SM; Direito R; Laurindo LF; Marton LT; Guiguer EL; Goulart RA; Tofano RJ; Carvalho ACA; Flato UAP; Capelluppi Tofano VA; Detregiachi CRP; Bueno PCS; Girio RSJ; Araújo AC · Antioxidants (Basel, Switzerland) · 2024
    Narrative review14 studies pooledMental Focus forGinkgo
  30. Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial.
    Calabrese C; Gregory WL; Leo M; Kraemer D; Bone K; Oken B · Journal of alternative and complementary medicine (New York, N.Y.) · 2009
    Randomized trial54 participantsProductivity Boost forBacopa
  31. Examining the nootropic effects of a special extract of Bacopa monniera on human cognitive functioning: 90 day double-blind placebo-controlled randomized trial.
    Stough C; Downey LA; Lloyd J; Silber B; Redman S; Hutchison C; Wesnes K; Nathan PJ · Phytotherapy research : PTR · 2009
    Randomized trial107 participantsProductivity Boost forBacopa
  32. An acute, double-blind, placebo-controlled crossover study of 320 mg and 640 mg doses of a special extract of Bacopa monnieri (CDRI 08) on sustained cognitive performance.
    Downey LA; Kean J; Nemeh F; Lau A; Poll A; Gregory R; Murray M; Rourke J; Patak B; Pase MP; Zangara A; Lomas J; Scholey A; Stough C · Phytotherapy research : PTR · 2014
    Randomized trial24 participantsProductivity Boost forBacopa
  33. [Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability].
    Kasper S; Schubert H · Fortschritte der Neurologie-Psychiatrie · 2009
    Meta-analysis10 studies pooledProductivity Boost forGinkgo
  34. Dietary Flavonoids and Human Cognition: A Meta-Analysis.
    Cheng N; Bell L; Lamport DJ; Williams CM · Molecular nutrition & food research · 2022
    Meta-analysis5,519 participants80 studies pooledProductivity Boost forGinkgo
  35. Limited cognitive benefits in Stage +2 postmenopausal women after 6 weeks of treatment with Ginkgo biloba.
    Elsabagh S; Hartley DE; File SE · Journal of psychopharmacology (Oxford, England) · 2005
    Randomized trial87 participantsProductivity Boost forGinkgo
  36. Efficacy and safety of Ginkgo biloba extract EGb 761 in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial.
    Gavrilova SI; Preuss UW; Wong JW; Hoerr R; Kaschel R; Bachinskaya N; GIMCIPlus Study Group · International journal of geriatric psychiatry · 2015
    Randomized trial160 participantsProductivity Boost forGinkgo
  37. Modulation of cognitive performance following single doses of 120 mg Ginkgo biloba extract administered to healthy young volunteers.
    Kennedy DO; Jackson PA; Haskell CF; Scholey AB · Human psychopharmacology · 2008
    Randomized trial78 participantsProductivity Boost forGinkgo
  38. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma.
    Quaranta L; Bettelli S; Uva MG; Semeraro F; Turano R; Gandolfo E · Ophthalmology · 2003
    Randomized trial27 participantsVision Support forGinkgo
  39. [Ginkgo extract in impaired vision--treatment with special extract EGb 761 of impaired vision due to dry senile macular degeneration].
    Fies P; Dienel A · Wiener medizinische Wochenschrift (1946) · 2002
    Randomized trial99 participantsVision Support forGinkgo
  40. Short-term effects of Ginkgo biloba extract on peripapillary retinal blood flow in normal tension glaucoma.
    Park JW; Kwon HJ; Chung WS; Kim CY; Seong GJ · Korean journal of ophthalmology : KJO · 2012
    Randomized trial30 participantsVision Support forGinkgo
  41. [The course of color vision in early diabetic retinopathy treated with Ginkgo biloba extract. A preliminary double-blind versus placebo study].
    Lanthony P; Cosson JP · Journal francais d'ophtalmologie · 1989
    Randomized trial29 participantsVision Support forGinkgo